非肝硬化性门静脉高压患者的前瞻性评估:一项单中心研究
这项单中心前瞻性研究纳入具有或存在非肝硬化性门静脉高压(NCPH)风险的患者,按有无门静脉高压特异性特征分为两组,均行基线肝活检并每6-12个月复查肝硬度(LSM)和影像。中位随访50个月,两组生存率和失代偿率相似;血小板≤100 K/mcL及LSM≥10 kPa者生存较低。
要点
- 无门静脉高压特异性特征的NCPH患者仍存在疾病进展风险,应密切监测。
- 血小板≤100 K/mcL者生存低于血小板>100 K/mcL者。
- LSM≥10 kPa者生存及无失代偿生存均低于LSM<10 kPa者。
核心结论
- 无论有无门静脉高压特异性特征,患者生存率或无失代偿生存率相似。
- 无特异性特征的患者仍有疾病进展风险,应密切监测。
- 血小板减少和LSM升高与严重肝病相关,而严重肝病与结局强相关。
研究设计与样本
- 单中心前瞻性研究,纳入具有或存在NCPH风险的患者。
- 按有无门静脉高压特异性特征(静脉曲张、侧支循环、门静脉高压性胃病或门静脉高压性出血)分为两组。
- 所有参与者均接受基线肝活检,并每6-12个月复查LSM和影像。
- 共纳入50例患者:无特异性特征组(I组)15例,有特异性特征组(II组)35例。
- 中位随访时间为50个月。
主要发现
- II组肝静脉压力梯度、门静脉高压无创指标均高于I组,血小板计数(PLT)低于I组。
- 两组生存率和失代偿率相似。
- PLT≤100 K/mcL者生存率低于PLT>100 K/mcL者。
- LSM≥10 kPa者生存率及无失代偿生存率均低于LSM<10 kPa者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Non-cirrhotic portal hypertension (NCPH) is a spectrum of liver diseases, including porto-sinusoidal vascular disorder, with portal hypertension (PH) in the absence of cirrhosis. The natural history and diagnostic approach to NCPH are not well understood. AIM: We aimed to evaluate disease progression and outcomes in NCPH. METHODS: Patients with or at risk for NCPH were enrolled in a single centre prospective study; two groups were formed based on the presence of specific features of PH, such as varices, collaterals, portal hypertensive gastropathy or portal hypertensive bleeding. All participants underwent a baseline liver biopsy. Liver stiffness measurement (LSM), and imaging were repeated every 6-12 months. RESULTS: Fifteen patients without specific features of PH (Group I), and 35 patients with specific features (Group II) were enrolled. The median follow-up time was 50 months. Group II had higher hepatic venous pressure gradients, non-invasive measures of PH and a lower platelet count (PLT) when compared to Group I. Rates of survival and decompensation were similar in both groups. Patients with PLT ≤100 K/mcL had lower survival compared to those with PLT >100 K/mcL. Patients with LSM ≥10 kPa had lower survival and survival without decompensation when compared to patients with LSM <10 kPa. CONCLUSIONS: Patients irrespective of specific features of PH had similar survival or survival without decompensation. Patients without specific features are at risk for disease progression and should be monitored closely. Thrombocytopenia and increased LSM are associated with severe forms of liver disease, which are strongly associated with outcomes.
引用
- Mironova M, Gopalakrishna H, Viana Rodriguez GM, et al. Prospective evaluation of patients with non-cirrhotic portal hypertension: A single centre study. Aliment Pharmacol Ther. 2024. PMID: 38629442. doi:10.1111/apt.17987
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。